A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis
Completed
Merck Sharp & Dohme Corp.
Phase 3
2009-03-24
This study will provide additional efficacy data for rizatriptan when used for an acute
migraine attack in patients already taking topiramate for migraine prophylaxis.
Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)
Completed
Merck Sharp & Dohme Corp.
Phase 3
1995-09-01
A study to compare rizatriptan 10 mg verse sumatriptan 100 mg in the treatment of migraine
attacks and duration of relief provided. This study will also provide additional efficacy
data on rizatriptan 5 mg and 10 mg for the treatment of migraine.
A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)
Completed
Merck Sharp & Dohme Corp.
Phase 3
2009-12-01
To provide long term safety data for rizatriptan in children and adolescents. The primary
hypothesis of the study is that rizatriptan is well tolerated in the long term treatment of
acute migraine in pediatric patients age 12-17 years.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
